We recently had the pleasure of partnering with Moelis & Company to host industry leaders from Private Equity and CDMOs to discuss GLP-1 Winners and Losers, considering the breadth of potential clinical benefits, sustainability of weight loss, patient access, and the long-term implications for multiple players across biopharma and pharma services. Dean Griffiths PhD Brian Quinn Sam Ulin Matt Pfister Alec M. Arek Kurkciyan Francois Saint-Lo Michael Aiello Bruno Brandao Dennis Crandall #clearviewhcp #lifesciencesconsulting #moelis #privateequity #GLP1 #obesity #YourFutureisinClearView
ClearView Healthcare Partners’ Post
More Relevant Posts
-
Biosciences Ph.D. | Precision Medicine Strategy Advisor | Biochem | Biophysics | Micro | Molecular | Oncology | Protein Biology | Structural Biology
Catch me and the Diaceutics Team at ASCO, ready to tell you more about our complimentary Precision Medicine 101 educational program. A high-level educational program with a broad overview of precision medicine including who it benefits, when and where it should be weaved into drug development and commercialization planning. #ASCO2024 #ASCO24 #PrecisionMedicine #BetterTestingBetterTreatment
Are you or your team faced with the challenge of understanding the critical steps to successful implementation of a precision medicine drug? Our Business Development Managers Ryan McCreanor and Jack Abraham are at ASCO until Monday offering complementary bookings post conference for our new Precision Medicine 101 training session for pharma and biotech companies. Message one of the team to learn more and book a session for your team. ✔️Designed and delivered by precision medicine experts ✔️ Delivered virtually to facilitate global teams ✔️ Addressing the key considerations and benefits of precision medicines througout the drug development and commercialisation process #ASCO2024 #ASCO24 #PrecisionMedicine
-
Are you or your team faced with the challenge of understanding the critical steps to successful implementation of a precision medicine drug? Our Business Development Managers Ryan McCreanor and Jack Abraham are at ASCO until Monday offering complementary bookings post conference for our new Precision Medicine 101 training session for pharma and biotech companies. Message one of the team to learn more and book a session for your team. ✔️Designed and delivered by precision medicine experts ✔️ Delivered virtually to facilitate global teams ✔️ Addressing the key considerations and benefits of precision medicines througout the drug development and commercialisation process #ASCO2024 #ASCO24 #PrecisionMedicine
-
In a letter to shareholders, Dr Philippe Wolgen, CEO of CLINUVEL Group, discusses the Company’s financial results for FY2023; clinical progress; and the Company’s next steps. “In learning from other bio-pharmaceutical cases, we have come to the notion of entrepreneurship being a discipline centred around risk management. At the same time, one is all too aware of opportunity costs coming with a plan spanning two decades or more. However, the ultimate outcome of realising a grander vision, turning CLINUVEL into a global brand, surpasses those costs. The Group has the potential of being globally recognised for its values, attitude, and seeing through complex plans by overcoming adversity.” — Dr Philippe Wolgen, CEO, CLINUVEL Group Read the full letter: https://lnkd.in/gHKgW-c3
-
'Real World Evidence 101' goes live in 12 days at 1pm GMT (Monday 19th February). The session, designed for industry colleagues by SPARK Evidence & One MSL will serve as an introduction to RWE in the context of Medical Affairs. Join myself & Samantha Oliver for what promises to be an enlightening session. You can register here: https://lnkd.in/ghYFeBD3 We hope you can join us then! #freewebinar #realworldevidence #MSL #pharma #medicalaffairs
I'm pleased to report that preparation is underway for a forthcoming webinar from One MSL in collaboration with SPARK Evidence. The interactive session is the first of a wide slate of topics planned for this year. 'Real World Evidence 101' will serve as an introduction to the entitled subject and will be of great value to biopharma industry colleagues - myself included. I'll be joined by Samantha Oliver, Director & Founder of SPARK Evidence when the webinar goes live at 1PM GMT on Monday 19 February. Submit your registration request for the free session here: https://lnkd.in/ghYFeBD3 I hope you can join us then! #freewebinar #pharma #realworldevidence #MSL
-
-
Latest insights from James West who leads our #lifesciences efforts. Well worth reading for those looking at this sector.
Always a pleasure to share my views with Scrip. James West, Managing Director in our Healthcare Group, recently shared his outlook on the 2024 biopharma market with Scrip, Citeline Commercial in their article series. https://lnkd.in/ecthTnW5 #LincolnPerspectives
Scrip Asks…What Does 2024 Hold for Biopharma? - Lincoln International LLC
-
𝗔𝗹𝗹𝗶𝗮𝗻𝗰𝗲 𝗜𝗻𝘁𝗲𝗴𝗿𝗮𝘁𝗶𝗼𝗻 𝗠𝗮𝗻𝗮𝗴𝗲𝗺𝗲𝗻𝘁 | 𝗜𝗻𝘁𝗲𝗿𝗻𝗮𝘁𝗶𝗼𝗻𝗮𝗹 𝗕𝘂𝘀𝗶𝗻𝗲𝘀𝘀 𝗧𝗿𝗮𝗻𝘀𝗳𝗼𝗿𝗺𝗮𝘁𝗶𝗼𝗻 | 𝗥𝗶𝘀𝗸 𝗠𝗮𝗻𝗮𝗴𝗲𝗺𝗲𝗻𝘁
Looking forward to catching up with my Alliance colleagues at the upcoming ASAP BioPharma conference in Boston (https://lnkd.in/gtQ4-qRA). Honored to be presenting on one of my favorite subjects: "Enhancing your Alliance Management toolkit: Tailoring information to drive effective decision-making" and co-presenting both the biopharma and CRO/CDMO views. See you in a few weeks. #ASAPBioPharma, #AllianceManagement
-
-
Day 2 at #COGUK, and here's the thing: we're not just talking #RBQM. We're living it, breathing it, and flipping it on its head at booth 6. 🎉 Think of risk not as a hurdle but as your north star in the complex universe of clinical trials. That's our pitch—not a sales one, but a vision of a future where navigating uncertainty becomes our greatest asset. Swing by for a chat that's less about transactions and more about transformations. Because in the quest to advance clinical research, the real adventure lies in the risks we're bold enough to embrace. Neil Watkins Benjamin Brummitt Tim Collard Duncan Hall Jo Gower Pharmaceutical Business Conference Group #fdacompliance #fdaregulations #clinicaltrials
-
-
BioPharma & HealthTech Competitive Strategy & Insights | Digital & AI Solutions | Gene & Cell Therapy | Vaccines
Thoughts on this? >> Weeks after closing Bristol Myers deal, Karuna's ex-CEO heads to Blackstone-backed Anthos >> Comment below! >>> lqventures.com #strategy #competitiveintelligence #marketing #productmarketing #pharmaceutical #healthcare #pharma #biotech
Weeks after closing Bristol Myers deal, Karuna's ex-CEO heads to Blackstone-backed Anthos
https://endpts.com
-
Register for our #ASCO2024 preview webinar below!
Head of Clients for Europe & JPAC - Commercial Marketing Insights and Real World Evidence / Commercial Leader / Healthcare Consulting / People Leader / Research and Data Analytics / Life Sciences
Join my colleagues Stephanie Hawthorne, Jay Grisolano and Kelly Clapp, UCLA's Deborah Wong, and BiotechTV's Brad Loncar for a discussion of their perspectives on anticipated data readouts at this year’s ASCO preview webinar on the impact on clinical practice, and the commercial implications for pharma and the financial sector. Register now at https://lnkd.in/gxghVb4u #ASCO24
ASCO 2024 Preview Webinar
go.oracle.com
-
💥 Unveiling the REAL expectations from Service Providers in the Clinical Trial Industry! 💼 Dive into the insights shared by our dynamic panelists at the 20th BioPharma Clinical Trials Nexus in San Diego! 🔍 #ClinicalTrials #IndustryInsights #FlippingTheDialogue 💪
-
